Hasegawa Y - Search Results

1

Implication of clinical pathway care for community-acquired pneumonia in a community hospital: early switch from an intravenous beta-lactam plus a macrolide to an oral respiratory fluoroquinolone.

Shindo Y, Sato S, Maruyama E, Ohashi T, Ogawa M, Imaizumi K, Hasegawa Y. Shindo Y, et al. Among authors: hasegawa y. Intern Med. 2008;47(21):1865-74. doi: 10.2169/internalmedicine.47.1343. Epub 2008 Nov 4. Intern Med. 2008. PMID: 18981629 Free article.

2

The natural course of osteoarthritis of the hip due to subluxation or acetabular dysplasia.

Hasegawa Y, Iwata H, Mizuno M, Genda E, Sato S, Miura T. Hasegawa Y, et al. Arch Orthop Trauma Surg. 1992;111(4):187-91. doi: 10.1007/BF00571474. Arch Orthop Trauma Surg. 1992. PMID: 1622705

3

Detection of Pneumocystis carinii, Mycobacterium tuberculosis, and cytomegalovirus in human immunodeficiency virus (HIV)-infected patients with hemophilia by polymerase chain reaction of induced sputum samples.

Shimomoto H, Hasegawa Y, Takagi N, Ichiyama S, Takamatsu J, Saito H, Shimokata K. Shimomoto H, et al. Among authors: hasegawa y. Intern Med. 1995 Oct;34(10):976-81. doi: 10.2169/internalmedicine.34.976. Intern Med. 1995. PMID: 8563099 Free article.

4

Bystander tumoricidal effect and gap junctional communication in lung cancer cell lines.

Imaizumi K, Hasegawa Y, Kawabe T, Emi N, Saito H, Naruse K, Shimokata K. Imaizumi K, et al. Among authors: hasegawa y. Am J Respir Cell Mol Biol. 1998 Feb;18(2):205-12. doi: 10.1165/ajrcmb.18.2.2821. Am J Respir Cell Mol Biol. 1998. PMID: 9476907

5

Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction.

Imaizumi K, Kawabe T, Ichiyama S, Kikutani H, Yagita H, Shimokata K, Hasegawa Y. Imaizumi K, et al. Among authors: hasegawa y. Am J Physiol. 1999 Jul;277(1):L49-57. doi: 10.1152/ajplung.1999.277.1.L49. Am J Physiol. 1999. PMID: 10409230

6

Avoidance of bone marrow suppression using A-5021 as a nucleoside analog for retrovirus-mediated herpes simplex virus type I thymidine kinase gene therapy.

Hasegawa Y, Nishiyama Y, Imaizumi K, Ono N, Kinoshita T, Hatano S, Saito H, Shimokata K. Hasegawa Y, et al. Cancer Gene Ther. 2000 Apr;7(4):557-62. doi: 10.1038/sj.cgt.7700134. Cancer Gene Ther. 2000. PMID: 10811473

7

Effect of erythromycin on matrix metalloproteinase-9 and cell migration.

Hashimoto N, Kawabe T, Hara T, Imaizumi K, Wakayama H, Saito H, Shimokata K, Hasegawa Y. Hashimoto N, et al. Among authors: hasegawa y. J Lab Clin Med. 2001 Mar;137(3):176-83. doi: 10.1067/mlc.2001.112726. J Lab Clin Med. 2001. PMID: 11241027

8

Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer.

Noguchi M, Imaizumi K, Kawabe T, Wakayama H, Horio Y, Sekido Y, Hara T, Hashimoto N, Takahashi M, Shimokata K, Hasegawa Y. Noguchi M, et al. Among authors: hasegawa y. Cancer Gene Ther. 2001 Jun;8(6):421-9. doi: 10.1038/sj.cgt.7700320. Cancer Gene Ther. 2001. PMID: 11498762

9

Perfusion and ventilation isotope lung scans in constrictive bronchiolitis obliterans. A series of three cases.

Hasegawa Y, Imaizumi K, Sekido Y, Iinuma Y, Kawabe T, Hashimoto N, Shimokata K. Hasegawa Y, et al. Respiration. 2002;69(6):550-5. doi: 10.1159/000066464. Respiration. 2002. PMID: 12457011

10

CD40 plays a crucial role in lipopolysaccharide-induced acute lung injury.

Hashimoto N, Kawabe T, Imaizumi K, Hara T, Okamoto M, Kojima K, Shimokata K, Hasegawa Y. Hashimoto N, et al. Among authors: hasegawa y. Am J Respir Cell Mol Biol. 2004 Jun;30(6):808-15. doi: 10.1165/rcmb.2003-0197OC. Epub 2003 Dec 23. Am J Respir Cell Mol Biol. 2004. PMID: 14693668

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,784 results

Search Page

Filters